Literature DB >> 8757855

The (alpha2-->8)-linked polysialic acid capsule of group B Neisseria meningitidis modifies multiple steps during interaction with human macrophages.

R C Read1, S Zimmerli, C Broaddus, D A Sanan, D S Stephens, J D Ernst.   

Abstract

Group B Neisseria meningitidis causes systemic disease, including meningitis, after initial colonization and subsequent penetration of nasopharyngeal mucosa, a tissue which is richly populated by macrophages. In an initial effort to characterize the interaction of N. meningitidis and mature human macrophages, the influence of the alpha2-->8) -linked polysialic acid capsule on the interaction of N. meningitidis with human monocyte-derived macrophages was investigated with a capsulate case isolate and an isogenic Tn916-derived noncapsulate transformant. The capsulate strain was fourfold less adherent to the macrophage surface after cold incubation, although adherence of both strains was significantly increased after opsonization with nonimmune C5-depleted serum. When opsonized inocula were adjusted so that they adhered to macrophages in equal numbers, the two strains were internalized at equivalent rates and both entered membrane-bound compartments (phagosomes). Colocalization of bacteria with the late endosomal and lysosomal marker lysosome-associated membrane protein revealed that fusion of lysosomes with phagosomes containing the capsulate organism was significantly reduced 10 and 30 min after entry, but by 1 h, no difference between the strains was observed. Once internalized, meningococci were effectively killed, although more rapid killing of the capsulate strain was observed over the first 3 h. These results indicate that the (alpha2-->8)-linked polysialic acid capsule modifies the interaction of meningococci with human macrophages at multiple steps, including adherence to the macrophage surface and phagosome-lysosome fusion. Moreover, the discordance between the kinetics of phagosome- lysosome fusion and bacterial killing suggests that a nonlysosomal mechanism may be responsible for a significant fraction of macrophage killing of N. meningitidis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8757855      PMCID: PMC174209          DOI: 10.1128/iai.64.8.3210-3217.1996

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  32 in total

1.  Sialic acid of group B Neisseria meningitidis regulates alternative complement pathway activation.

Authors:  G A Jarvis; N A Vedros
Journal:  Infect Immun       Date:  1987-01       Impact factor: 3.441

2.  The carrier state: Neisseria meningitidis.

Authors:  C V Broome
Journal:  J Antimicrob Chemother       Date:  1986-07       Impact factor: 5.790

3.  The third component of complement (C3) is responsible for the intracellular survival of Leishmania major.

Authors:  D M Mosser; P J Edelson
Journal:  Nature       Date:  1987 May 28-Jun 3       Impact factor: 49.962

4.  Antibody-dependent cell-mediated antibacterial activity of human mononuclear cells. I. K lymphocytes and monocytes are effective against meningococi in cooperation with human imune sera.

Authors:  G H Lowell; L F Smith; M S Artenstein; G S Nash; R P MacDermott
Journal:  J Exp Med       Date:  1979-07-01       Impact factor: 14.307

5.  Mutants of Salmonella typhimurium that cannot survive within the macrophage are avirulent.

Authors:  P I Fields; R V Swanson; C G Haidaris; F Heffron
Journal:  Proc Natl Acad Sci U S A       Date:  1986-07       Impact factor: 11.205

6.  Intracellular trafficking in Mycobacterium tuberculosis and Mycobacterium avium-infected macrophages.

Authors:  S Xu; A Cooper; S Sturgill-Koszycki; T van Heyningen; D Chatterjee; I Orme; P Allen; D G Russell
Journal:  J Immunol       Date:  1994-09-15       Impact factor: 5.422

7.  Antibody-dependent mononuclear cell-mediated antimeningococcal activity. Comparison of the effects of convalescent and postimmunization immunoglobulins G, M, and A.

Authors:  G H Lowell; L F Smith; J M Griffiss; B L Brandt; R P MacDermott
Journal:  J Clin Invest       Date:  1980-08       Impact factor: 14.808

8.  Antibody-dependent cell-mediated antibacterial activity of human mononuclear cells. II. Immune specificity of antimeningococcal activity.

Authors:  L F Smith; G H Lowell
Journal:  J Infect Dis       Date:  1980-06       Impact factor: 5.226

9.  Fluorescent carbocyanine dyes allow living neurons of identified origin to be studied in long-term cultures.

Authors:  M G Honig; R I Hume
Journal:  J Cell Biol       Date:  1986-07       Impact factor: 10.539

10.  Formation of a novel phagosome by the Legionnaires' disease bacterium (Legionella pneumophila) in human monocytes.

Authors:  M A Horwitz
Journal:  J Exp Med       Date:  1983-10-01       Impact factor: 14.307

View more
  25 in total

1.  Bacterial [Cu,Zn]-cofactored superoxide dismutase protects opsonized, encapsulated Neisseria meningitidis from phagocytosis by human monocytes/macrophages.

Authors:  Kate L R Dunn; Jayne L Farrant; Paul R Langford; J Simon Kroll
Journal:  Infect Immun       Date:  2003-03       Impact factor: 3.441

Review 2.  The immunopathogenesis of meningococcal disease.

Authors:  A J Kvalsvig; D J Unsworth
Journal:  J Clin Pathol       Date:  2003-06       Impact factor: 3.411

3.  The Neisseria meningitidis capsule is important for intracellular survival in human cells.

Authors:  Maria Rita Spinosa; Cinzia Progida; Adelfia Talà; Laura Cogli; Pietro Alifano; Cecilia Bucci
Journal:  Infect Immun       Date:  2007-04-30       Impact factor: 3.441

4.  Inhibition of macrophage apoptosis by Neisseria meningitidis requires nitric oxide detoxification mechanisms.

Authors:  Anne J Tunbridge; Tania M Stevanin; Margaret Lee; Helen M Marriott; James W B Moir; Robert C Read; David H Dockrell
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

5.  Nitric oxide metabolism in Neisseria meningitidis.

Authors:  Muna F Anjum; Tânia M Stevanin; Robert C Read; James W B Moir
Journal:  J Bacteriol       Date:  2002-06       Impact factor: 3.490

6.  Interaction of Neisseria meningitidis with human dendritic cells.

Authors:  A Kolb-Mäurer; A Unkmeir; U Kämmerer; C Hübner; T Leimbach; A Stade; E Kämpgen; M Frosch; G Dietrich
Journal:  Infect Immun       Date:  2001-11       Impact factor: 3.441

7.  Nitric oxide detoxification systems enhance survival of Neisseria meningitidis in human macrophages and in nasopharyngeal mucosa.

Authors:  Tânia M Stevanin; James W B Moir; Robert C Read
Journal:  Infect Immun       Date:  2005-06       Impact factor: 3.441

8.  Distinct cell death programs in monocytes regulate innate responses following challenge with common causes of invasive bacterial disease.

Authors:  Steve J Webster; Marc Daigneault; Martin A Bewley; Julie A Preston; Helen M Marriott; Sarah R Walmsley; Robert C Read; Moira K B Whyte; David H Dockrell
Journal:  J Immunol       Date:  2010-07-23       Impact factor: 5.422

9.  The class A macrophage scavenger receptor is a major pattern recognition receptor for Neisseria meningitidis which is independent of lipopolysaccharide and not required for secretory responses.

Authors:  Leanne Peiser; Menno P J De Winther; Katherine Makepeace; Michael Hollinshead; Philip Coull; Joyce Plested; Tatsuhiko Kodama; E Richard Moxon; Siamon Gordon
Journal:  Infect Immun       Date:  2002-10       Impact factor: 3.441

10.  NsrR: a key regulator circumventing Salmonella enterica serovar Typhimurium oxidative and nitrosative stress in vitro and in IFN-gamma-stimulated J774.2 macrophages.

Authors:  Nicola J Gilberthorpe; Margaret E Lee; Tania M Stevanin; Robert C Read; Robert K Poole
Journal:  Microbiology (Reading)       Date:  2007-06       Impact factor: 2.777

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.